Table 3 HPV prevalence and genotype distribution among HIV-1 seropositive and HIV-seronegative women in Cape Coast, Ghana
HPV genotypes | HIV-1 positive (NÂ =Â 160) | HIV negative (NÂ =Â 169) | P-value |
|---|---|---|---|
n (%) | n (%) | ||
HPV 16 | 17 (10.6) | 1 (0.6) | <0.0001 |
HPV 18 | 17 (10.6) | 3 (1.8) | 0.001 |
HPV 31 | 13 (8.1) | 1 (0.6) | 0.001 |
HPV 33 | 8 (5.0) | 7 (4.1) | 0.71 |
HPV 35 | 19 (11.9) | 9 (5.3) | 0.03 |
HPV 39 | 7 (4.4) | 3 (1.8) | 0.17 |
HPV 45 | 10 (6.3) | 2 (1.2) | 0.01 |
HPV 51 | 2 (1.3) | 0 (0.0) | 0.14 |
HPV 52 | 19 (11.9) | 4 (2.4) | 0.001 |
HPV 56 | 13 (8.1) | 6 (3.6) | 0.07 |
HPV 58 | 18 (11.3) | 7 (4.1) | 0.01 |
HPV 59 | 8 (5.0) | 2 (1.2) | 0.04 |
HPV 68 | 15 (9.4) | 3 (1.8) | 0.002 |
Any HPV | 120 (75.0) | 72 (42.6) | <0.0001 |
Any hr.-HPV | 105 (65.6) | 51 (30.2) | <0.0001 |
HPV 16/18 (bivalent vaccine types) | 34 (21.3) | 4 (2.4) | <0.0001 |
HPV 16/18/6/11 (quadrivalent vaccine types) | 53 (33.1) | 7 (4.1) | <0.0001 |
HPV 16/18/31/33/45/52/58/6/11 (nonavalent vaccine types) | 89 (55.6) | 29 (17.2) | <0.0001 |
Low risk types only | 15 (9.4) | 21 (12.4) | 0.38 |
HPV 6 | 12 (7.5) | 1 (0.6) | 0.001 |
HPV 11 | 10 (6.3) | 2 (1.2) | 0.01 |
HPV 6 and/or 11 | 21 (13.1) | 3 (1.8) | <0.0001 |
Multiple types | |||
 2–5 | 64 (52.5) | 36 (21.3) | <0.0001 |
  > 5 | 13 (8.1) | 0 (0.0) | <0.0001 |